Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Alto Neuroscience Inc
Profile last edited on: 5/22/2023      CAGE: 8CT17      UEI: D435D8QN99S4

Business Identifier: Clinical-stage biopharmaceutical company creating precision medicines through AI-driven biomarker platform.
Year Founded
2019
First Award
2020
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

165 Lyell Street
Los Altos, CA 94022
   (917) 420-3247
   info@altoneuroscience.com
   www.altoneuroscience.com
Location: Single
Congr. District: 18
County: Santa Clara

Public Profile

Anchored on a platform built from data aggregated at scale and proprietary artificial intelligence analysis tools, Alto Neuroscience is developing a new generation of biomarker-based diagnostic tests and personalized treatments for use in mental health. Anchored in a platform built from data aggregated at scale and proprietary artificial intelligence analysis tools - enabling doctors to assist in treating patients suffering from neurological disorders - the assembled team has been expanded to include well established neuroscientists and business executives with experience commercializing products for the brain

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$988,093
Phase II Dollars
$2,200,606
Total Awarded
$3,188,699

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2022 2 NIH $3,188,699
Project Title: Validating of Machine Learning-Based Eeg Treatment Biomarkers in Depression

Key People / Management

  Amit Etkin -- Founder and CEO

  Lauren Blake -- Data scientist

  Bruce Morimoto -- Vice President, Drug Development

  Dan Segal -- Co-Founder and COO

  Nick Smith -- Chief Financial Officer

  Wei Wu -- Co-Founder andCTO

Company News

There are no news available.